High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 12, Issue 1, 2010, Pages

  Vázquez Del Mercado, Monica ^a,b   Palafox Sánchez, Claudia A ^a   Muñoz Valle, Jose F ^a   Orozco Barocio, Gerardo ^c   Oregon Romero, Edith ^a   Navarro Hernández, Rosa E ^a   Salazar Páramo, Mario ^a   Armendariz Borunda, Juan ^a   Gámez Nava, Jorge I ^a   Gonzalez Lopez, Laura ^d   Chan, Jason Y F ^e   Chan, Edward K L ^f   Satoh, Minoru ^e  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^c HOSPITAL GENERAL DE OCCIDENTE   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2GPI ANTIBODY; DOUBLE STRANDED DNA; NUCLEAR PROTEIN; RIBOSOMAL P; RNA HELICASE; RNA HELICASE A; SM ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIGEN; DEAD BOX PROTEIN; DHX9 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CHILD; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOADSORBENT; IMMUNOPRECIPITATION; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PRESCHOOL CHILD; PREVALENCE; RACE DIFFERENCE; SCHOOL CHILD; SCREENING TEST; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING; ADULT; BLOOD; IMMUNOLOGY; MASS SPECTROMETRY; MEXICO; MIDDLE AGED; ONSET AGE;

ADULT; AGE OF ONSET; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; DEAD-BOX RNA HELICASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOPRECIPITATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEXICO; MIDDLE AGED; NEOPLASM PROTEINS; PREVALENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77955474382     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2905     Document Type: Article

References (29)

1. Satoh M, Chan EK, Sobel ES, Kimpel DL, Yamasaki Y, Narain S, Mansoor R, Reeves WH. Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol 2007, 3:721-738. 20477023, 10.1586/1744666X.3.5.721.
2. Satoh M, Vazquez-Del Mercado M, Chan EK. Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol 2009, 19:219-228. 10.1007/s10165-009-0155-3, 19277826, 2876095.
3. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
4. Yamasaki Y, Narain S, Yoshida H, Hernandez L, Barker T, Hahn PC, Sobel ES, Richards HB, Chan EK, Reeves WH, Satoh M. Autoantibodies to RNA helicase A: a new serological marker of early lupus. Arthritis Rheum 2007, 56:596-604. 10.1002/art.22329, 17265494.
5. Colla E, Lee SD, Sheen MR, Woo SK, Kwon HM. TonEBP is inhibited by RNA helicase A via interaction involving the E'F loop. Biochem J 2006, 393:411-419. 10.1042/BJ20051082, 1383700, 16173919.
6. Takeda Y, Caudell P, Grady G, Wang G, Suwa A, Sharp GC, Dynan WS, Hardin JA. Human RNA helicase A is a lupus autoantigen that is cleaved during apoptosis. J Immunol 1999, 163:6269-6274.
7. Chan JYF, Yoshida H, Mizutani A, Yamasaki Y, Sobel ES, Chan EKL, Reeves WH, Satoh M. Autoantibodies to RNA helicase A as a new serologic marker of early SLE. From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies Autoantigens, Autoantibodies and Autoimmunity Proceedings 9th Dresden Symposium on Autoantibodies 2009, 61-70. Lengerich, Germany: Pabst Science Publishers, Conrad K, Chan EKL, Fritzler MJ, Sack U, Shoenfeld Y, Wiik A.
8. Guzman J, Cardiel MH, Arce-Salinas A, Sanchez-Guerrero J, Alarcon-Segovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992, 19:1551-1558.
9. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, Hanly JG, Isenberg DA, Kalunian K, Nived O, Petri M, Sanchez-Guerrero J, Snaith M, Sturfelt G. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:809-813. 10.1002/art.1780400506, 9153540.
10. Satoh M, Langdon JJ, Hamilton KJ, Richards HB, Panka D, Eisenberg RA, Reeves WH. Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein. J Clin Invest 1996, 97:2619-2626. 10.1172/JCI118711, 507349, 8647956.
11. Okano Y, Targoff IN, Oddis CV, Fujii T, Kuwana M, Tsuzaka K, Hirakata M, Mimori T, Craft J, Medsger JTA. Anti-U5 small nuclear ribonucleoprotein(snRNP) antibodies: a rare anti-U snRNP specificity. Clin Immunol Immunopathol 1996, 81:41-47. 10.1006/clin.1996.0155, 8808640.
12. Yoshida H, Satoh M, Behney KM, Lee C-G, Richards HB, Shaheen VM, Yang JQ, Singh RR, Reeves WH. Effect of an exogenous trigger on the pathogenesis of lupus in NZB × NZW (F1) mice. Arthritis Rheum 2002, 46:2235-2244. 10.1002/art.10441, 2291543, 12209530.
13. Liao HJ, Kobayashi R, Mathews MB. Activities of adenovirus virus-associated RNAs: purification and characterization of RNA binding proteins. Proc Natl Acad Sci USA 1998, 95:8514-8519. 10.1073/pnas.95.15.8514, 21107, 9671709.
14. Analyze Menu, Documentation, ImageJ. , http://rsb.info.nih.gov/ij/docs/menus/analyze.html
15. Yamasaki Y, Narain S, Hernandez L, Barker T, Ikeda K, Segal MS, Richards HB, Chan EK, Reeves WH, Satoh M. Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases. Arthritis Res Ther 2006, 8:R111-120. 10.1186/ar2000, 1779422, 16846524.
16. Palafox Sánchez CA, Satoh M, Chan EK, Carcamo WC, Muñoz Valle JF, Orozco Barocio G, Oregon Romero E, Navarro Hernández RE, Salazar Páramo M, Cabral Castañeda A, Vázquez Del Mercado M. Reduced IgG anti-small nuclear ribonucleoproteins autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies. Arthritis Res Ther 2009, 11:R27. 10.1186/ar2621, 2688261, 19232124.
17. Magsaam J, Gharavi AE, Parnassa AP, Weissbach H, Brot N, Elkon KB. Quantification of lupus anti-ribosome P antibodies using a recombinant P2 fusion protein and determination of the predicted amino acid sequence of the autoantigen in patients' mononuclear cells. Clin Exp Immunol 1989, 76:165-171. 1541824, 2758693.
18. Satoh M, Mizutani A, Behney KM, Kuroda Y, Akaogi J, Yoshida H, Nacionales DC, Hirakata M, Ono N, Reeves WH. X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus. Int Immunol 2003, 15:1117-1124. 10.1093/intimm/dxg110, 12917264.
19. Wang J, Satoh M, Kabir F, Shaw M, Domingo MA, Mansoor R, Behney KM, Dong X, Lahita RG, Richards HB, Reeves WH. Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum 2001, 44:2367-2370. 10.1002/1529-0131(200110)44:10<2367::AID-ART400>3.0.CO;2-I, 11665978.
20. Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 1994, 180:2341-2346. 10.1084/jem.180.6.2341, 2191761, 7964507.
21. Satoh M, Hamilton KJ, Ajmani AK, Dong X, Wang J, Kanwar Y, Reeves WH. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol 1996, 157:3200-3206.
22. Nacionales DC, Kelly KM, Lee PY, Zhuang H, Li Y, Weinstein JS, Sobel E, Kuroda Y, Akaogi J, Satoh M, Reeves WH. Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane). Am J Pathol 2006, 168:1227-1240. 10.2353/ajpath.2006.050125, 1606560, 16565497.
23. Lee PY, Weinstein JS, Nacionales DC, Scumpia PO, Li Y, Butfiloski E, van Rooijen N, Moldawer L, Satoh M, Reeves WH. A novel type I IFN-producing cell subset in murine lupus. J Immunol 2008, 180:5101-5108.
24. Nacionales DC, Kelly-Scumpia KM, Lee PY, Weinstein JS, Lyons R, Sobel E, Satoh M, Reeves WH. Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum 2007, 56:3770-3783. 10.1002/art.23023, 17968932.
25. Lee PY, Kumagai Y, Li Y, Takeuchi O, Yoshida H, Weinstein J, Kellner ES, Nacionales D, Barker T, Kelly-Scumpia K, van Rooijen N, Kumar H, Kawai T, Satoh M, Akira S, Reeves WH. TLR7-dependent and Fc{gamma}R-independent production of type I interferon in experimental mouse lupus. J Exp Med 2008, 205:2995-3006. 10.1084/jem.20080462, 2605237, 19047436.
26. Takeuchi O, Akira S. Recognition of viruses by innate immunity. Immunol Rev 2007, 220:214-224. 10.1111/j.1600-065X.2007.00562.x, 17979849.
27. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533. 10.1056/NEJMoa021933, 14561795.
28. Alarcon-Segovia D. Mixed connective tissue disease. Appearance of antibodies to ribonucleoprotein following corticosteroid treatment. J Rheumatol 1979, 6:694-699.
29. Ellman MH, Pachman L, Medof ME. Raynaud's phenomenon and initially seronegative mixed connective tissue disease. J Rheumatol 1981, 8:632-634.